Celcuity (CELC) Current Deferred Tax Assets (2018 - 2023)
Celcuity (CELC) reported Current Deferred Tax Assets of $79088.0 for Q2 2023, down 76.24% on a YoY basis from $332824.0 in Q2 2022, and up 122.18% quarter-over-quarter from $35597.0 in Q1 2023.
Celcuity (CELC) Current Deferred Tax Assets (2018 - 2023) Analysis & Trends
Celcuity has reported Current Deferred Tax Assets for 6 years, with the latest figure at $79088.0 in Q2 2023.
- For the quarter ending Q2 2023, Current Deferred Tax Assets fell 76.24% year-over-year to $79088.0; the trailing twelve-month figure through Jun 2023 stood at $79088.0 (down 76.24% YoY), and the FY2022 full-year result was $33195.0, up 49.91% from the prior year.
- Current Deferred Tax Assets for Q2 2023 stood at $79088.0, up from $35597.0 in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $349147.0 in Q3 2022, with the low at $13719.0 in Q1 2021.
- Historically, Current Deferred Tax Assets has averaged $93383.3 across 5 years, with a median of $34032.5 in 2020.
- Annual changes were most pronounced in 2022 — Current Deferred Tax Assets soared 1142.82% — and 2023, when it sank 79.12%.
- Celcuity's Current Deferred Tax Assets stood at $28743.0 in 2019, then increased by 21.32% to $34870.0 in 2020, then slumped by 36.5% to $22144.0 in 2021, then surged by 49.91% to $33195.0 in 2022, then soared by 138.25% to $79088.0 in 2023.
- The last three Current Deferred Tax Assets figures came in at $79088.0 (Q2 2023), $35597.0 (Q1 2023), and $33195.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 79,088.00 |
| Jun 30, 2023 | 79,088.00 |
| Mar 31, 2023 | 35,597.00 |
| Mar 31, 2023 | 35,597.00 |
| Dec 31, 2022 | 33,195.00 |
| Dec 31, 2022 | 33,195.00 |
| Sep 30, 2022 | 349,147.00 |
| Sep 30, 2022 | 349,147.00 |
| Jun 30, 2022 | 332,824.00 |
| Jun 30, 2022 | 332,824.00 |
| Mar 31, 2022 | 170,503.00 |
| Mar 31, 2022 | 170,503.00 |
| Dec 31, 2021 | 22,144.00 |
| Dec 31, 2021 | 22,144.00 |
| Jun 30, 2021 | 121,307.00 |
| Jun 30, 2021 | 121,307.00 |
| Mar 31, 2021 | 13,719.00 |
| Mar 31, 2021 | 13,719.00 |
| Mar 31, 2020 | 34,870.00 |
| Mar 31, 2020 | 34,870.00 |